Dr. Kelly Chibale, Founder & Director, University of Cape Town Holistic Drug Discovery & Development Centre
April 23, 2024
In this episode, we discuss the use of artificial intelligence (AI) in drug discovery, particularly in lower-resource settings. AI typically requires advanced computing infrastructure and tremendous power and other resources to utilize, but Dr. Chibale's team at the University of Cape Town (South Africa) has adapted these tools for use on lower-capacity computing systems. Their principal aim is to support African-centric drug discovery, utilizing data from local populations and tailoring products to their specific genotypic and phenotypic characteristics.
The BWC Global Forum: Biotech, Biosecurity & Beyond